PERCEPTIVE ADVISORS LLC
CIK 1224962
13F filing for Q2 2026・No. 752
- Holdings
- US$6.66B
- Quarter change
- +US$1.54B
- Entries
- 109
- Net bought (estimate)
- —
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
No filing the quarter before to compare with.
Largest holdings
101 stocks worth US$6.43B, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES ICOM NEW | — | 2,035,986 | US$681.63M | 10.61% |
| SYRESPYRE THERAPEUTICS INCCOM NEW | — | 4,319,496 | US$383.48M | 5.97% |
| CELCUITY INCCOM | — | 3,197,200 | US$334.49M | 5.21% |
| ASCENDIS PHARMA A/SORD SHS | — | 1,163,721 | US$310.39M | 4.83% |
| RYTMRHYTHM PHARMACEUTICALS INCCOM | — | 2,586,295 | US$287.16M | 4.47% |
| ROIVROIVANT SCIENCES LTDSHS | — | 8,085,461 | US$286.14M | 4.45% |
| RLAYRELAY THERAPEUTICS INCCOM | — | 14,106,187 | US$263.93M | 4.11% |
| TRAVERE THERAPEUTICS INCCOM | — | 3,752,574 | US$213.18M | 3.32% |
| KARDKARDIGAN INCCOM | — | 8,200,662 | US$195.59M | 3.04% |
| NUVLNUVALENT INCCOM | — | 1,580,505 | US$195.19M | 3.04% |
Sign in (free) to see its 50 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.